CL2E-SN38 TFA

Product Specifications

Target

Drug-Linker Conjugates for ADC

Related Pathways

Antibody-drug Conjugate/ADC Related

Bioactivity

CL2E-SN-38 TFA, a structurally stable and highly releasable antibody drug conjugate (ADC), comprises SN-38, the active metabolite of Irinotecan derived from camptothecins, known for its Topoisomerase I inhibitory activity [1].

Molecular Formula

C89H117F3N14O26

Molecular Weight

1855.95

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

OPEF01520-10MG 10 mg

Progesterone-17-OH-3-CMO Antigen : BSA

View Details

UQB35172-01 50 mg

2-[ (3-Methylbut-2-en-1-yl) sulfanyl]benzoic acid

View Details

UQB35172-02 0.5 g

2-[ (3-Methylbut-2-en-1-yl) sulfanyl]benzoic acid

View Details

TP721837M 100 µg

T2R16 Human Recombinant Protein, Synthetic Nanodisc

View Details

orb1915884-01 10 nmol

Hsa-miR-650 miRNA Antagomir

View Details

orb1915884-02 20 nmol

Hsa-miR-650 miRNA Antagomir

View Details